CANCER IMMUNOL IMMUN 润色咨询

Cancer Immunology, Immunotherapy

出版年份：暂无数据 年文章数：2295 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-02-06 148202a4m20(暂无昵称)

    请问已经under review11个月了，发邮件没有回复，这种情况怎么办？

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2025-01-09 扣1992 来自黑龙江省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向：肿瘤免疫
    经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2024-12-01 stayreal1992 来自山东省

    偏重的研究方向：肿瘤;肿瘤免疫
    经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2024-12-12 空漠菌 来自北京

    偏重的研究方向：肿瘤免疫
    经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。
    另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-08-24 ms3000000087643737

    请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。

    3

    展开3条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2021-10-06 Ykkkk

    请问文章接收多久后能收到版权协议和proof？

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-12-24 actin 5 来自湖北省

    审稿速度:4.0
    偏重的研究方向：免疫;肿瘤免疫
    经验分享：变三区了，性价比不高

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-09-02 ms3000001278720978

    偏重的研究方向：肿瘤
    经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办

    12

    展开12条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-11-07 ms1000001339998745

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1190585, encodeId=38d7119058505, content=请问已经under review11个月了，发邮件没有回复，这种情况怎么办？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220509/2b7facd4011a46e3ae2917f4bf3bf049/6328c748b7f0407f9efd69ce9b200021.jpg, createdBy=0c695270486, createdName=148202a4m20(暂无昵称), createdTime=Sun Feb 06 21:37:18 CST 2022, time=2022-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2247247, encodeId=686e224e24760, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向：肿瘤免疫<br>经验分享：朋友们，现在这个杂志是不是只能选OA交版面费了？感谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKN1Ot5ibrSUopzI45n7IsLlBeWMbiaN8fDt7NMcfXtn0xCml7jksRXicqvXd8FDPd6xbdP9PFpLDQhg/132, createdBy=20965199906, createdName=扣1992, createdTime=Thu Jan 09 12:26:31 CST 2025, time=2025-01-09, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=2240218, encodeId=50482240218bd, content=偏重的研究方向：肿瘤;肿瘤免疫<br>经验分享：请问各位朋友一般with editor 多久才会送审 已经1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a203126443, createdName=stayreal1992, createdTime=Sun Dec 01 10:48:37 CST 2024, time=2024-12-01, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2241981, encodeId=d18522419817e, content=偏重的研究方向：肿瘤免疫<br>经验分享：请问大家都几个reviewer invited呀，我这 10 more were invited。<br>另外这个期刊如果审稿了的话中的概率大吗，还是会审好久拒了呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/t95qibZWpoZpSIXww4RRD1dcZERxzWcicUKMy0t3ibfdkqicHY5bAtES7x6Eg4fshrBOb5xzTmjtC7hrjibJBspILEA/132, createdBy=788c5242713, createdName=空漠菌, createdTime=Thu Dec 12 10:43:08 CST 2024, time=2024-12-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1240756, encodeId=fc0c1240e56a6, content=请问大家一般都是几个审稿人，现在状态是8 reviewers invited。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dc636158720, createdName=ms3000000087643737, createdTime=Wed Aug 24 18:08:57 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058144, encodeId=450d1058144ec, content=请问文章接收多久后能收到版权协议和proof？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ecec5428596, createdName=Ykkkk, createdTime=Wed Oct 06 16:50:32 CST 2021, time=2021-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2107270, encodeId=6ccf210e27079, content=审稿速度:4.0<br>偏重的研究方向：免疫;肿瘤免疫<br>经验分享：变三区了，性价比不高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba0e1737976, createdName=actin 5, createdTime=Sat Dec 24 11:04:02 CST 2022, time=2022-12-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1242780, encodeId=dd2c1242e80ab, content=偏重的研究方向：肿瘤<br>经验分享：editor appointed40天了，一点消息都没，写了催稿也没回复，怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3dd08137055, createdName=ms3000001278720978, createdTime=Fri Sep 02 11:37:31 CST 2022, time=2022-09-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098932, encodeId=dc27209893218, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：找审稿人找了4个月没有任何消息，非常非常慢，还找不到怎么撤稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55c48175790, createdName=ms1000001339998745, createdTime=Mon Nov 07 10:20:40 CST 2022, time=2022-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094619, encodeId=151f20946196b, content=想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b88119717, createdName=ms6000002045898850, createdTime=Wed Oct 19 00:06:10 CST 2022, time=2022-10-19, status=1, ipAttribution=)]
    2022-10-19 ms6000002045898850

    想问下有碰到过显示没有访问投稿页面权限的吗？为啥没有权限呢

    1

    展开1条回复
共152条页码: 1/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分